Meta-analysis of predictive models to assess the clinical validity and utility for patient-centered medical decision making: application to the CAncer of the Prostate Risk Assessment (CAPRA)
The Cancer of the Prostate Risk Assessment (CAPRA) score was designed and validated several times to predict the biochemical recurrence-free survival after a radical prostatectomy. Our objectives were, first, to study the clinical validity of the CAPRA score, and, second, to assess its clinical util...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
07 January 2019
|
| In: |
BMC medical informatics and decision making
Year: 2019, Volume: 19, Pages: 1-12 |
| ISSN: | 1472-6947 |
| DOI: | 10.1186/s12911-018-0727-2 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1186/s12911-018-0727-2 Verlag, Volltext: https://bmcmedinformdecismak.biomedcentral.com/track/pdf/10.1186/s12911-018-0727-2 
|
| Author Notes: | Marine Lorent, Haïfa Maalmi, Philippe Tessier, Stéphane Supiot, Etienne Dantan and Yohann Foucher |
| Summary: | The Cancer of the Prostate Risk Assessment (CAPRA) score was designed and validated several times to predict the biochemical recurrence-free survival after a radical prostatectomy. Our objectives were, first, to study the clinical validity of the CAPRA score, and, second, to assess its clinical utility for stratified medicine from an original patient-centered approach. |
|---|---|
| Item Description: | Gesehen am 31.05.2019 |
| Physical Description: | Online Resource |
| ISSN: | 1472-6947 |
| DOI: | 10.1186/s12911-018-0727-2 |